Bone Loss in Intestinal Inflammation Disease Yields to Osteoclastogenesis Inhibition.
作者信息
Strober Warren
机构信息
Mucosal Immunity Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
出版信息
Cell Mol Gastroenterol Hepatol. 2022;14(4):945-946. doi: 10.1016/j.jcmgh.2022.07.015. Epub 2022 Aug 7.
Abstract
摘要
相似文献
1
Bone Loss in Intestinal Inflammation Disease Yields to Osteoclastogenesis Inhibition.
Cell Mol Gastroenterol Hepatol. 2022;14(4):945-946. doi: 10.1016/j.jcmgh.2022.07.015. Epub 2022 Aug 7.
2
Osteogenesis, Osteoclastogenesis and their Crosstalk in Lipopolysaccharide-induced Periodontitis in Mice.
Chin J Dent Res. 2021 Apr 23;24(1):33-39. doi: 10.3290/j.cjdr.b1105871.
3
Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
Int Immunopharmacol. 2017 Nov;52:230-237. doi: 10.1016/j.intimp.2017.09.018. Epub 2017 Sep 23.
4
Recombinant thrombomodulin lectin-like domain attenuates Porphyromonas gingivalis lipopolysaccharide-induced osteoclastogenesis and periodontal bone resorption.
J Periodontol. 2021 Nov;92(11):1622-1634. doi: 10.1002/JPER.20-0732. Epub 2021 Feb 6.
5
Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms.
J Oral Biosci. 2020 Jun;62(2):123-130. doi: 10.1016/j.job.2020.02.002. Epub 2020 Feb 17.
6
Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo.
J Cell Physiol. 2019 Mar;234(3):2719-2729. doi: 10.1002/jcp.27087. Epub 2018 Aug 5.
7
Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
J Cell Physiol. 2018 Jan;233(1):476-485. doi: 10.1002/jcp.25907. Epub 2017 Aug 17.
8
Fgf9 Negatively Regulates Bone Mass by Inhibiting Osteogenesis and Promoting Osteoclastogenesis Via MAPK and PI3K/AKT Signaling.
J Bone Miner Res. 2021 Apr;36(4):779-791. doi: 10.1002/jbmr.4230. Epub 2021 Jan 23.
9
The effects of tranylcypromine on osteoclastogenesis and .
FASEB J. 2019 Sep;33(9):9828-9841. doi: 10.1096/fj.201802242RR. Epub 2019 Jul 10.
10
Myeloid-Specific PTP1B Deficiency Attenuates Inflammation-Induced and Ovariectomy-Induced Bone Loss in Mice by Inhibiting Osteoclastogenesis.
J Bone Miner Res. 2022 Mar;37(3):505-514. doi: 10.1002/jbmr.4478. Epub 2021 Dec 30.
引用本文的文献
1
Synergistic exacerbation of periprosthetic osteolysis by inflammatory bowel disease and titanium ions: Impaired osteogenesis of BMSCs via PI3K/AKT signaling.
Mater Today Bio. 2025 Aug 23;34:102236. doi: 10.1016/j.mtbio.2025.102236. eCollection 2025 Oct.
本文引用的文献
1
Intestinal Inflammation Promotes MDL-1 Osteoclast Precursor Expansion to Trigger Osteoclastogenesis and Bone Loss.
Cell Mol Gastroenterol Hepatol. 2022;14(4):731-750. doi: 10.1016/j.jcmgh.2022.07.002. Epub 2022 Jul 12.
2
A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
Clin Rev Allergy Immunol. 2016 Aug;51(1):48-58. doi: 10.1007/s12016-015-8521-8.
3
Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis.
J Exp Med. 2010 Mar 15;207(3):579-89. doi: 10.1084/jem.20090516. Epub 2010 Mar 8.
4
Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4816-21. doi: 10.1073/pnas.0900463106. Epub 2009 Feb 27.
5
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.
Gut. 2005 Apr;54(4):479-87. doi: 10.1136/gut.2004.044370.
6
Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients.
Clin Exp Immunol. 2004 Dec;138(3):491-8. doi: 10.1111/j.1365-2249.2004.02643.x.
7
Bone resorption by osteoclasts.
Science. 2000 Sep 1;289(5484):1504-8. doi: 10.1126/science.289.5484.1504.
Zotero 插件